TELO·87975F104·US·equity·Healthcare - Biotechnology-13D/G
TELO (TELOMIR PHARMACEUTICALS INC) is held by 15 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($375,958), GEODE CAPITAL MANAGEMENT, LLC ($323,954), MILLENNIUM MANAGEMENT LLC ($167,778). Net institutional sentiment: Bearish.
See how TELO's score breaks down across 4 SEC sources
Showing 1-20 of 21
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer